REMISSION ACCOMPLISHED WITH LUMOXITI
LUMOXITI is a prescription medicine used to treat hairy cell leukemia that has come back or has not responded to previous treatment in adults who have received at least 2 other therapies, including a type of medicine called a purine nucleoside analog (PNA).
In a large clinical study of 80 patients whose HCL returned following at least 2 prior treatments, 41% of patients (33/80) experienced a complete response, meaning no evidence of HCL was found in their blood or bone marrow.
YOU ARE NOW LEAVING THIS SITE
This link will take you to a site that is maintained by a third party who is solely responsible for its contents.